We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents.
- Authors
Silvestris, Nicola; Munafò, Antonio; Brunetti, Oronzo; Burgaletto, Chiara; Scucces, Luisa; Bernardini, Renato
- Abstract
Keywords: cancer therapy; Sars-Cov2; drug-to-drug interaction; metabolism; dose adjustement EN cancer therapy Sars-Cov2 drug-to-drug interaction metabolism dose adjustement 1 3 3 07/24/20 20200721 NES 200721 Introduction The unprecedented global pandemic caused by coronavirus 2 (SARS-Cov2) drew medical attention toward patients with co-morbid disorders, who are more exposed to prognostically unfavorable outcomes ([1]). JAMA J Am Med Assoc. (2020) 323: 1824-36. 10.1001/jama.2020.601932282022 7 Back, D, Marzolini, C, Hodge, C, Marra, F, Boyle, A, Gibbons, S, COVID-19 treatment in patients with comorbidities: awareness of drug-drug interactions. (2007) 76: 391-6. 13 Tseng, A, Foisy, M, Important drug-drug interactions in HIV-infected persons on antiretroviral therapy: an update on new interactions between HIV and Non-HIV drugs.
- Subjects
COVID-19; ANTINEOPLASTIC agents; DRUG interactions; HORMONE receptor positive breast cancer
- Publication
Frontiers in Oncology, 2020, Vol 10, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2020.01340